Login / Signup

Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies.

Jan A BurgerPaula CramerPaul M BarrMarie-Sarah DilhuydyAnthony MatoJohn C ByrdStephen ChangThorsten GraefTony LinAlessandra Tedeschi
Published in: British journal of haematology (2019)
Keyphrases
  • chronic lymphocytic leukemia